BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Riedel O, Ohlmeier C, Enders D, Elsässer A, Vizcaya D, Michel A, Eberhard S, Schlothauer N, Berg J, Garbe E. The contribution of comorbidities to mortality in hospitalized patients with heart failure. Clin Res Cardiol 2018;107:487-97. [PMID: 29404680 DOI: 10.1007/s00392-018-1210-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Hao B, Chen J, Cai Y, Li H, Zhu Z, Xu W, Liu H. Association between allostatic load and adverse outcomes among older patients with heart failure with preserved ejection fraction.. [DOI: 10.21203/rs.3.rs-2105574/v1] [Reference Citation Analysis]
2 Budde H, Hassoun R, Mügge A, Kovács Á, Hamdani N. Current Understanding of Molecular Pathophysiology of Heart Failure With Preserved Ejection Fraction. Front Physiol 2022;13:928232. [DOI: 10.3389/fphys.2022.928232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wintrich J, Abdin A, Böhm M. Management strategies in heart failure with preserved ejection fraction. Herz 2022. [PMID: 35524007 DOI: 10.1007/s00059-022-05119-5] [Reference Citation Analysis]
4 Cai Z, Wu C, Xu Y, Cai J, Zhao M, Zu L. The NO-cGMP-PKG Axis in HFpEF: From Pathological Mechanisms to Potential Therapies. Aging and disease 2022. [DOI: 10.14336/ad.2022.0523] [Reference Citation Analysis]
5 Gu W, Xu C, Li Z, Li ZZ. Echocardiographic changes in elderly patients with heart failure with reduced ejection fraction after sacubitril-valsartan treatment. Cardiovasc Diagn Ther 2021;11:1093-100. [PMID: 34815959 DOI: 10.21037/cdt-21-355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Fisser C, Götz K, Hetzenecker A, Debl K, Zeman F, Hamer OW, Poschenrieder F, Fellner C, Stadler S, Maier LS, Pfeifer M, Buchner S, Arzt M. Obstructive sleep apnoea but not central sleep apnoea is associated with left ventricular remodelling after acute myocardial infarction. Clin Res Cardiol 2021;110:971-82. [PMID: 32519084 DOI: 10.1007/s00392-020-01684-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
7 Bruno C, Silvestrini A, Calarco R, Favuzzi AMR, Vergani E, Nicolazzi MA, d'Abate C, Meucci E, Mordente A, Landolfi R, Mancini A. Anabolic Hormones Deficiencies in Heart Failure With Preserved Ejection Fraction: Prevalence and Impact on Antioxidants Levels and Myocardial Dysfunction. Front Endocrinol (Lausanne) 2020;11:281. [PMID: 32477267 DOI: 10.3389/fendo.2020.00281] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Wintrich J, Kindermann I, Ukena C, Selejan S, Werner C, Maack C, Laufs U, Tschöpe C, Anker SD, Lam CSP, Voors AA, Böhm M. Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future. Clin Res Cardiol 2020;109:1079-98. [PMID: 32236720 DOI: 10.1007/s00392-020-01633-w] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 26.5] [Reference Citation Analysis]
9 Contaifer D Jr, Buckley LF, Wohlford G, Kumar NG, Morriss JM, Ranasinghe AD, Carbone S, Canada JM, Trankle C, Abbate A, Van Tassell BW, Wijesinghe DS. Metabolic modulation predicts heart failure tests performance. PLoS One 2019;14:e0218153. [PMID: 31220103 DOI: 10.1371/journal.pone.0218153] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
10 Chou YY, Yu TH, Tung YC. Do Hospital and Physician Volume Thresholds for the Volume-Outcome Relationship in Heart Failure Exist? Med Care 2019;57:54-62. [PMID: 30439795 DOI: 10.1097/MLR.0000000000001022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
11 Abdel-basset M, Gamal A, Manogaran G, Son LH, Long HV. A novel group decision making model based on neutrosophic sets for heart disease diagnosis. Multimed Tools Appl 2020;79:9977-10002. [DOI: 10.1007/s11042-019-07742-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 10.3] [Reference Citation Analysis]
12 Holstiege J, Akmatov MK, Störk S, Steffen A, Bätzing J. Higher prevalence of heart failure in rural regions: a population-based study covering 87% of German inhabitants. Clin Res Cardiol 2019;108:1102-6. [DOI: 10.1007/s00392-019-01444-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
13 Ergatoudes C, Schaufelberger M, Andersson B, Pivodic A, Dahlström U, Fu M. Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry. Clin Res Cardiol 2019;108:1025-33. [PMID: 30788622 DOI: 10.1007/s00392-019-01430-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 14.7] [Reference Citation Analysis]
14 Shoaib A, Farag M, Nolan J, Rigby A, Patwala A, Rashid M, Kwok CS, Perveen R, Clark AL, Komajda M, Cleland JGF. Mode of presentation and mortality amongst patients hospitalized with heart failure? A report from the First Euro Heart Failure Survey. Clin Res Cardiol 2019;108:510-9. [PMID: 30361818 DOI: 10.1007/s00392-018-1380-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
15 Abraityte A, Aukrust P, Kou L, Anand IS, Young J, Mcmurray JJV, van Veldhuisen DJ, Gullestad L, Ueland T. T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF. Clin Res Cardiol 2019;108:133-41. [PMID: 30051179 DOI: 10.1007/s00392-018-1331-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
16 Sramko M, Wichterle D, Melenovsky V, Franekova J, Clemens M, Fukunaga M, Kautzner J. Independent effect of atrial fibrillation on natriuretic peptide release. Clin Res Cardiol 2019;108:142-9. [DOI: 10.1007/s00392-018-1332-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
17 Wienbergen H, Pfister O, Hochadel M, Fach A, Backhaus T, Bruder O, Remppis BA, Maeder MT, von Scheidt W, Pauschinger M, Senges J, Hambrecht R; for the RAID-HF (Registry Analysis of Iron Deficiency-Heart Failure) Study Group. Long-term effects of iron deficiency in patients with heart failure with or without anemia: the RAID-HF follow-up study. Clin Res Cardiol 2019;108:93-100. [DOI: 10.1007/s00392-018-1327-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
18 Lachowska K, Bellwon J, Narkiewicz K, Gruchała M, Hering D. Long-term effects of device-guided slow breathing in stable heart failure patients with reduced ejection fraction. Clin Res Cardiol 2019;108:48-60. [PMID: 29943271 DOI: 10.1007/s00392-018-1310-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
19 Wintrich J, Kindermann I, Böhm M. [Update on heart failure]. Herz 2020;45:158-69. [PMID: 29869700 DOI: 10.1007/s00059-018-4715-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]